Tazzle is typically administered orally, with peak plasma concentrations reached within 2 hours of ingestion. Unlike some PDE5 inhibitors, Tazzle can be taken with or without food, although consuming a heavy meal may delay its onset of action. The drug is metabolized primarily by the liver and eliminated from the body via faces and urine.